Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Risico op herseninfarct bij COVID-19 groter dan bij influenza
aug 2020 | Neuro-vasculair